Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „repaglinide“
Suchtreffer
Begriffe & Kennungen
Karvea · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenKarvea · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenKarvezide · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenKarvezide · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenKarvezide · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenKarvezide · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenKarvezide · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenLeflunomide Zentiva (previously Leflunomide Winthrop) · 4.5 · 25 Effect on repaglinide (CYP2C8 substrate) There was an increase in mean repaglinide Cmax and AUC (1.7- and 2
Eintrag öffnenLeflunomide Zentiva (previously Leflunomide Winthrop) · 4.5 · 8 There was an increase in mean repaglinide Cmax and AUC (1.7- and 2.4-fold, respectively), following repeated
Eintrag öffnenLeflunomide Zentiva (previously Leflunomide Winthrop) · 4.5 · Effect on repaglinide (CYP2C8 substrate)
Eintrag öffnenLeflunomide Zentiva (previously Leflunomide Winthrop) · 4.5 · Effect on repaglinide (CYP2C8 substrate) There was an increase in mean repaglinide Cmax and AUC (1.7- and 2.4-
Eintrag öffnenLeflunomide medac · 4.5 · Effect on repaglinide (CYP2C8 substrate) There was an increase in mean repaglinide Cmax and AUC (1.7- and 2.4-
Eintrag öffnenLeflunomide ratiopharm · 4.5 · Effect on repaglinide (CYP2C8 substrate) There was an increase in mean repaglinide Cmax and AUC (1.7- and 2.4-
Eintrag öffnenNovoNorm · 4.3 · • Hypersensitivity to repaglinide or to any of the excipients listed in section 6.1. • Diabetes mellitus type
Eintrag öffnenNovoNorm · 4.3 · • Hypersensitivity to repaglinide or to any of the excipients listed in section 6.1. • Diabetes mellitus type
Eintrag öffnenNovoNorm · 4.3 · • Hypersensitivity to repaglinide or to any of the excipients listed in section 6.1. • Diabetes mellitus type
Eintrag öffnenNovoNorm · 4.5 · 14 repaglinide, may be altered by substances which influence these cytochrome P-450 enzymes via inhibition or
Eintrag öffnenNovoNorm · 4.5 · 15 In a study conducted in healthy volunteers, the concomitant administration of repaglinide (a single dose of
Eintrag öffnenNovoNorm · 4.5 · 24 can be increased if CYP2C8 is inhibited. Consequently metabolism, and by that clearance of repaglinide, may
Eintrag öffnenNovoNorm · 4.5 · 25 In a study conducted in healthy volunteers, the concomitant administration of repaglinide (a single dose of
Eintrag öffnen